Papers matching “lymph node status prediction” 32
Not finding it? Sign in to also search OpenAlex live.
-
Use of Merlin Assay to identify patients with a low-risk for SN metastasis in a prospective multicenter Dutch study of a primary melanoma gene-signature (CP-GEP model) to predict sentinel node status during COVID-19.2022 Journal of Clinical Oncology conference-abstract Medicine Cutaneous Melanoma Detection and Management
Evalyn E.A.P. Mulder, Antoine Veringa, Antien L. Mooyaart, Jvalini T. Dwarkasing, Dennie Tempel, Jos A. van der Hage, +5 more
3citations -
Bridging prediction and reality: AI-based external validation of predictive models for lymph node metastasis in gastric cancer2026 European Journal of Surgical Oncology article Medicine Gastric Cancer Management and Outcomes Open access
Lúcio Lara Santos, Anna Carolina Finamore, Suzanne Sarah Gisbertz, Uberto Fumagalli Romario, Wojciech Kielan, Riccardo Rosati, +36 more
1citations -
Prediction of axillary response in 5,262 patients with node-positive breast cancer treated with neoadjuvant chemotherapy: Results from the prospective multicenter AXSANA/EUBREAST-03/AGO-B-053 study.2026 Journal of Clinical Oncology conference-abstract Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies
Maggie Banys‐Paluchowski, Thorsten Kühn, Steffi Hartmann, Jana de Boniface, Nina Caroline Ditsch, Oreste Gentilini, +15 more
0citations -
The prognostic performance of PREDICT+ in patients (pts) with HER2-positive (HER2+) early-stage breast cancer (EBC).2021 Journal of Clinical Oncology conference-abstract Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies
Elisa Agostinetto, Lieveke Ameye, Samuel Martel, Philippe Georges Aftimos, Noam Falbel Ponde, Christian Maurer, +14 more
1citations -
Diagnostic Value, Oncologic Outcomes, and Safety Profile of Image-Guided Surgery Technologies During Robot-Assisted Lymph Node Dissection with Sentinel Node Biopsy for Prostate Cancer2021 Journal of Nuclear Medicine article Medicine Prostate Cancer Diagnosis and Treatment Open access
Elio Mazzone, Paolo Dell’Oglio, N. Grivas, Esther M.K. Wit, Maarten L. Donswijk, Alberto Briganti, +2 more
62citations -
International assessment and validation of the prognostic role of lymph node ratio in patients with resected pancreatic head ductal adenocarcinoma2021 HepatoBiliary Surgery and Nutrition article Medicine Pancreatic and Hepatic Oncology Research Open access
Gaëtan‐Romain Joliat, Ismaïl Labgaa, Dionisios V. Vrochides, Alessandro Zerbi, Gennaro Nappo, Julie Périnel, +7 more
13citations -
Disease extent according to baseline [18F]fluorodeoxyglucose PET/CT and molecular subtype: prediction of axillary treatment response after neoadjuvant systemic therapy for breast cancer2024 British journal of surgery article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
Florien J G van Amstel, Cornelis Maarten de Mooij, Janine M. Simons, Cristina Mitea, P. J. van Diest, Patricia Joan Nelemans, +29 more
6citations -
Prediction of Isolated Local Recurrence After Resection of Pancreatic Ductal Adenocarcinoma: A Nationwide Study2024 Annals of Surgical Oncology article Medicine Pancreatic and Hepatic Oncology Research Open access
Iris W.J.M. van Goor, Paul C. M. Andel, Marc G. Besselink, Bert A. Bonsing, Koop P Bosscha, O. R. C. Busch, +20 more
5citations -
Predictive performance of breast cancer index (BCI) and clinical treatment score post-5 years (CTS5) in the IDEAL study.2022 Journal of Clinical Oncology conference-abstract Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies
Gerrit‐Jan Liefers, Iris Noordhoek, Hein Putter, Jenna Wong, Natalia Siuliukina, Yi Zhang, +5 more
4citations -
Assessment of risk of overall and late distant recurrence by Breast Cancer Index in postmenopausal women with early-stage, HR+ breast cancer in the TEAM trial.2023 Journal of Clinical Oncology conference-abstract Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
John M.S. Bartlett, Keying Xu, Jenna Wong, Gregory R. Pond, Yi Zhang, Melanie Spears, +12 more
1citations -
Breast cancer index (BCI) predicts benefit of two-and-a-half versus five years of extended endocrine therapy in HR+ breast cancer patients treated in the ideal trial.2020 Journal of Clinical Oncology conference-abstract Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies
Gerrit‐Jan Liefers, Iris Noordhoek, Kai Treuner, Hein Putter, Yi Zhang, Elma Meershoek‐Klein Kranenbarg, +3 more
4citations -
Pathology of Tumors Associated With Pathogenic Germline Variants in 9 Breast Cancer Susceptibility Genes2022 JAMA Oncology article Biochemistry, Genetics and Molecular Biology BRCA gene mutations in cancer Open access
Nasim Mavaddat, Leila Dorling, Jamie Allen, Anna González‐Neira, Renske Keeman, Manjeet K. Bolla, +85 more
171citations